Hologic, Inc. (HOLX) Tops Q1 EPS by 2c; Guides Q2, Raises FY12 Outlook
Hologic, Inc. (NASDAQ: HOLX) reported Q1 EPS of $0.34, $0.02 better than the analyst estimate of $0.32. Revenue for the quarter came in at $472.7 million versus the consensus estimate of $466.51 million.
Hologic, Inc. sees Q2 2012 EPS of $0.33, versus the consensus of $0.33. Hologic, Inc. sees Q2 2012 revenue of $470-$475 million, versus the consensus of $471.01 million.
Hologic, Inc. sees FY2012 EPS of $1.36-$1.38, versus prior guidance of $1.35-$1.37 and the consensus of $1.36.
For earnings history and earnings-related data on Hologic, Inc. (HOLX) click here.
Hologic, Inc. sees Q2 2012 EPS of $0.33, versus the consensus of $0.33. Hologic, Inc. sees Q2 2012 revenue of $470-$475 million, versus the consensus of $471.01 million.
Hologic, Inc. sees FY2012 EPS of $1.36-$1.38, versus prior guidance of $1.35-$1.37 and the consensus of $1.36.
For earnings history and earnings-related data on Hologic, Inc. (HOLX) click here.